@article{18061f45d9024b85859d9b141c1ce405,
title = "Personal Control Over Decisions to Participate in Research by Persons With Histories of Both Substance Use Disorders and Criminal Justice Supervision",
abstract = "Individuals must feel free to exert personal control over decisions regarding research participation. We present an examination of participants{\textquoteright} perceived personal control over, as well as reported pressures and threats from others, influencing their decision to join a study assessing the effectiveness of extended-release naltrexone in preventing opioid dependence relapse. Most participants endorsed a strong sense of control over the decision; few reported pressures or threats. Although few in number, participants{\textquoteright} brief narrative descriptions of the pressures and threats are illuminating and provide context for their perceptions of personal control. Based on this work, we propose a useful set of tools to help ascertain participants{\textquoteright} sense of personal control in joining research.",
keywords = "criminal justice supervision, decision making, perceived personal control, research ethics, substance use disorder",
author = "Chen, {Donna T.} and Ko, {Tomohiro M.} and Allen, {Ashleigh A.} and Bonnie, {Richard J.} and Suratt, {Colleen E.} and Appelbaum, {Paul S.} and Nunes, {Edward V.} and Friedmann, {Peter D.} and Lee, {Joshua D.} and Gordon, {Michael S.} and Ryan McDonald and Donna Wilson and Boney, {Tamara Y.} and Murphy, {Sean M.} and O{\textquoteright}Brien, {Charles P.}",
note = "Funding Information: The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The extended-release naltrexone prevention study was supported by the National Institute on Drug Abuse (NIDA) through a collaborative clinical trial mechanism, PAR-07-232 (R01DA024549, to Dr. Friedmann; R01DA024550, to Dr. Gordon; R01DA024553, to Dr. O{\textquoteright}Brien; R01DA024554, to Dr. Nunes; and R01DA024555, to Dr. Lee), and additional support (K24DA022412, to Dr. Nunes). Dr. Murphy{\textquoteright}s work was also supported by NIDA (P30DA040500). Trial medication was provided in kind from an investigator-initiated grant from Alkermes. Funding from the Dana Foundation to Dr. O{\textquoteright}Brien supported the conduct of a five-site pilot study (38861 and 38882). ClinicalTrials.gov number, NCT00781898. Publisher Copyright: {\textcopyright} 2018, {\textcopyright} The Author(s) 2018. Copyright: Copyright 2018 Elsevier B.V., All rights reserved.",
year = "2018",
month = apr,
day = "1",
doi = "10.1177/1556264618755243",
language = "English (US)",
volume = "13",
pages = "160--172",
journal = "Journal of Empirical Research on Human Research Ethics",
issn = "1556-2646",
publisher = "University of California Press",
number = "2",
}